Unpublished, uncontrolled small study claims that experimental exosome treatment shortens recovery time to five days for patients with severe Covid-19. Further human trials required to prove it truly works. February 9, 2021February 9, 2021Dr. Barry Dworkin Medical Mythbusting Commentary for February 9, 2021 [display_podcast] Source:Experimental cancer drug could help hospitalised coronavirus patients recover within five days, Israeli trial claims Related posts: Interesting approach using monoclonal antibodies to treat Covid-19 infections. However clinical trials must follow to confirm in vitro findings. Vulnerable populations to be the focus in a new Canadian COVID-19 antibody study. UBC, Université de Sherbrooke, and Cornell University researchers report a new enzyme-blocking compound delivered in a nasal spray that effectively treats delta variant infection in mice. Human trials dependent on securing funding. First step studying the outcomes of a one-and-done therapy using pegylated interferon lambda demonstrated that it helped curb severe COVID-19 infection-related hospitalizations. Covid-19exosomes